The IRB ensures that research involving human subjects complies with HHS and FDA regulations and protects participants' rights and welfare.
Does the FDA have an IRB?
Yes, the FDA requires an IRB to review and monitor biomedical research involving human subjects.
In practice, the FDA describes an IRB as a formally designated committee that weighs both ethical and scientific facets of a study before any participant is touched. Generally, its goal is to protect subjects’ rights, safety, and overall well‑being—essentially echoing the Common Rule’s safeguards. (Honestly, this alignment is reassuring.) The FDA’s oversight stretches to drug, biologic, and device trials that run under an IND or IDE.
What is the Institutional Review Board IRB charged with?
The IRB is charged with reviewing research protocols to ensure compliance with institutional, state, and federal regulations protecting human subjects.
This charge involves digging into risk‑benefit ratios, double‑checking informed‑consent procedures, and making sure the study meets accepted ethical standards. Typically, the board also keeps an eye on ongoing research for any adverse events or protocol hiccups. Institutions often line up the IRB’s duties with guidance from the HHS.
What are the 3 types of IRB?
The three review categories are Exempt, Expedited, and Full Board review.
Exempt reviews are reserved for low‑risk studies that fall neatly into specific statutory buckets; Expedited reviews cover minimal‑risk work that a qualified reviewer can handle without convening the full committee; Full Board review becomes necessary when a study carries more than minimal risk or involves vulnerable groups. In most cases, the type of review dictates how deep the documentation goes and how fast the approval comes.
| Review Type | Risk Level | Typical Timeline |
|---|
| Exempt | Minimal | 1–3 days |
| Expedited | Low to moderate | 5–7 days |
| Full Board | Moderate to high | 10–14 days |
What is included in IRB?
An IRB application must include the study hypothesis, design, methods, risk assessment, recruitment plan, and informed‑consent documents.
Beyond those basics, you’ll usually need to add data‑management plans, privacy safeguards, and a solid justification for who you’re recruiting. Providing a clear picture of how you’ll keep risks low helps the board decide if the study meets ethical standards. Many institutions even hand out templates to make the whole thing smoother.
Which type of IRB does not require approval?
Exempt research does not require full IRB approval because it falls under specific exemption categories.
Even though it’s “exempt,” you still have to send the study to the IRB for a determination that the exemption applies; the board’s role is limited to confirming eligibility. Typical exempt categories include educational surveys, anonymous behavioral observations, and certain public‑service activities. Researchers should still keep a copy of the exemption decision on file.
What is the charge of the IRB?
The IRB’s charge is to protect the rights, welfare, and privacy of research participants by reviewing all human‑subjects studies before they begin.
This responsibility stretches across both federally funded and unfunded projects, making sure no study moves forward without proper oversight. The board also keeps tabs on compliance throughout the study’s life, stepping in when protocols change or adverse events pop up. Failure to meet this charge can lead to regulatory penalties, which is why institutions take it seriously.
When an original consent form has been lost?
If the original signed consent form is lost, investigators must attempt to re‑obtain consent or document the loss and report it to the IRB.
Usually, the first step is to contact the participant and ask them to sign a new form—or, if you still have a copy of the original, to provide that. All communications and the reason for the loss should be logged in the study file. The IRB may then ask for a supplemental review to confirm everything remains compliant.
Who needs to be on the 1572?
The FDA Form 1572 must list every qualified investigator who will conduct the study, as well as the sponsor’s contact information.
Each investigator’s name, qualifications, and affiliation are required, no matter whether the trial runs in the United States or overseas. For medical‑device studies, a similar investigator agreement replaces Form 1572. Getting this form right is essential for FDA oversight of IND‑ or IDE‑based trials.
What happens if you don’t get IRB approval?
Conducting research without IRB approval can lead to institutional sanctions, loss of funding, and invalidation of data.
Researchers may face disciplinary action, including suspension or termination, and any publications that stem from the unapproved work could be retracted. Funding agencies—like the NIH—often view a lack of approval as a breach of contract, putting current and future grants at risk. The NIH stresses that compliance is a prerequisite for ethical research.
What does IRB exempt status mean?
Exempt status means the study involves minimal risk and fits one of the categories defined by the Common Rule, allowing a streamlined review.
Even when a study is exempt, you still have to submit it to the IRB for a formal determination that the exemption applies. Typically, a designated IRB staff member—not the full committee—handles that review. It’s a good idea to keep the exemption letter on file as part of your regulatory documentation.
What does IRB stand for?
IRB stands for Institutional Review Board.
The board is a committee made up of scientists, ethicists, and community representatives whose job is to protect human subjects in research. Its primary mission is to make sure studies are ethically sound and that participants fully understand the risks and benefits. The IRB operates under federal regulations codified in 45 CFR 46.
What is needed for IRB approval?
To obtain IRB approval, researchers must submit a complete protocol, risk/benefit analysis, and a consent form that meets regulatory standards.
The submission should also include a data‑safety monitoring plan, privacy protections, and any relevant investigator qualifications. The IRB will look to see whether risks are minimized and whether the study design holds up scientifically. Addressing reviewer comments promptly can speed the approval process.
How are IRB members selected?
IRB members are appointed by the Institutional Official after consultation with senior academic leaders to ensure diverse expertise.
The selection process seeks a balance of scientific, non‑scientific, and community perspectives, as required by federal regulations. Members receive appointment letters that spell out term length and responsibilities. Ongoing training—like the required CITI program—keeps everyone up to date on ethical standards.
How do I prepare for IRB?
Preparation involves confirming the need for review, completing required training, drafting a thorough protocol, and assembling consent documents before submission.
The following steps help streamline the process:
- Determine whether your project falls under the exemption, expedited, or full‑board category.
- Complete the mandatory online certification for researchers (e.g., CITI). CDC provides guidance on training requirements.
- Fill out the IRB Research Project Application with detailed methodology and risk mitigation.
- Prepare the informed‑consent document(s) that clearly explain the study purpose, procedures, and participant rights.
- Submit the complete package to the IRB office and track its status through the institution’s portal.
How long does it take to write IRB?
Writing an IRB application typically takes one to two weeks, while the board’s review may be completed in 7–10 business days.
Complex studies with multiple sites or high‑risk interventions often need extra time for drafting and internal approvals. Review timelines can stretch during peak submission periods or institutional breaks. If you haven’t heard back within the expected window, it’s wise to reach out to the IRB office.
